---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-337594"
form_type: "8-K"
ticker: "LITS"
cik: "0001262104"
company_name: "Lite Strategy, Inc."
filed_at: "2021-11-23T23:59:59+00:00"
generated_at: "2026-06-28T05:41:17.891703+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# MEI Pharma appoints Sujay Kango to board; Kevan Clemens resigns effective Nov 22, 2021

## Summary
- Kevan Clemens resigned from board effective Nov 22, 2021; no disagreement with company.
- Sujay Kango appointed to fill vacancy; 25+ years pharma/biotech experience.
- Kango received initial option grant of 25,000 shares vesting over three years.
- Kango also received pro-rated annual option grant of 33,334 shares vesting monthly over 12 months.
- Kango's expertise includes commercial launches; company aims to transition to commercial stage.

## SEC filing metadata
- accession: 0001193125-21-337594
- form_type: 8-K
- ticker: LITS
- cik: 0001262104
- company_name: Lite Strategy, Inc.
- filed_at: 2021-11-23T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1262104/000119312521337594/0001193125-21-337594-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1262104/000119312521337594/d261318d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-337594
- JSON: https://secwatch.observer/filing/0001193125-21-337594.json
- Plain text: https://secwatch.observer/filing/0001193125-21-337594.txt

## Key facts
- Executive change
  Sujay Kango was appointed as Director at Lite Strategy, Inc..
  - Action: appointed
  - Role: Director
  source text: On November 22, 2021, the Board appointed Mr. Sujay Kango to fill the vacancy on the Board resulting from the vacancy created by the resignation of Mr. Clemens.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1262104/000119312521337594/0001193125-21-337594-index.htm
- Executive change
  Kevan Clemens resigned as Director at Lite Strategy, Inc..
  - Action: resigned
  - Role: Director
  source text: On November 22, 2021, Mr. Kevan Clemens, a member of the Board of Directors (the “Board”) of MEI Pharma, Inc. (the “Company”) resigned from the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1262104/000119312521337594/0001193125-21-337594-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.